Show notes
Predictable cash flow is the whole game. In cannabis, predictable is the one thing almost nobody has.
Organigram CEO James Yamanaka came up over 20 years at British American Tobacco, where that discipline is the entire model. He thinks the opportunity starts there: trim the portfolio, stop chasing every trend, tighten the supply chain, lean on the science, and align operations. Germany's market could nearly double in the next two years, but capturing it will take more than expansion.
This week we sit down with James Yamanaka, CEO of Organigram:
A BAT perspective on cannabis
Why chasing…
Website: the-dime-177afd40.simplecast.com

